BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 641913)

  • 1. Comparison of therapy in severe systemic lupus erythematosus employing stratification techniques.
    McShane DJ; Porta J; Fries JF
    J Rheumatol; 1978; 5(1):51-8. PubMed ID: 641913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Objective evaluation of remote results of treatment of systemic lupus erythematosus].
    Ivanova MM; Nasonova VA; Folomeeva OM; Speranskiĭ AI; Kozlova VN
    Ter Arkh; 1977; 49(9):60-6. PubMed ID: 929421
    [No Abstract]   [Full Text] [Related]  

  • 4. Exacerbation of systemic lupus erythematosus after withdrawal of azathioprine therapy.
    Sharon E; Kaplan D; Diamond HS
    N Engl J Med; 1973 Jan; 288(3):122-4. PubMed ID: 4564983
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands.
    van den Wall Bake AW; Berden JH; Derksen RH; de Glas-Vos JW; Hagen EC
    Neth J Med; 1994 Dec; 45(6):280-4. PubMed ID: 7838244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
    Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
    Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
    Mok CC; Ying KY; Mak A; To CH; Szeto ML
    Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review.
    Khalidi NA; Rebello R; Robertson DD
    J Laryngol Otol; 2008 Dec; 122(12):1371-6. PubMed ID: 18282337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.
    Toubi E; Kessel A; Rosner I; Rozenbaum M; Paran D; Shoenfeld Y
    Scand J Immunol; 2006 Apr; 63(4):299-303. PubMed ID: 16623930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous pulsed therapy with prednisolone hemisuccinate in severe forms of systemic lupus erythematosus].
    Solakov P; Atanasov K
    Vutr Boles; 1988; 27(5):72-3. PubMed ID: 3213042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature.
    Breuer GS; Deeb M; Fisher D; Nesher G
    Semin Arthritis Rheum; 2005 Apr; 34(5):744-9. PubMed ID: 15846590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis.
    Tareyeva IE; Shilov EM; Gordovskaya NB
    Clin Nephrol; 1980 Nov; 14(5):233-7. PubMed ID: 6971722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy in systemic lupus erythematosus.
    Russell AS; Bretscher PA
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():194-8. PubMed ID: 3302253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled study of azathioprine in lupus.
    Schur PH; Christian CL
    N Engl J Med; 1968 May; 278(18):1019-20. PubMed ID: 4868713
    [No Abstract]   [Full Text] [Related]  

  • 15. Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients.
    Hahn BH; Kantor OS; Osterland CK
    Ann Intern Med; 1975 Nov; 83(5):597-605. PubMed ID: 1106277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic lupus erythematosus. Etiopathogenesis and immunosuppressive therapy].
    Clément F
    Schweiz Med Wochenschr; 1973 Oct; 103(40):1369-77. PubMed ID: 4755631
    [No Abstract]   [Full Text] [Related]  

  • 17. Lupus nephritis: clinical course in relation to treatment.
    Nanra RS; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1193-210. PubMed ID: 4803309
    [No Abstract]   [Full Text] [Related]  

  • 18. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR; Sato EI
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytostatic treatment of glomerular diseases. I. Effect of azathioprine on serum creatinine and proteinuria. Report from a Copenhagen Study Group of Renal Diseases.
    Balslov JT; Brun C; Jensen KB; Jorgensen F; Jorgensen HE; Larsen M; Lorenzen I; Thomsen AC
    Acta Med Scand; 1973 Jun; 193(6):483-91. PubMed ID: 4721957
    [No Abstract]   [Full Text] [Related]  

  • 20. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.